Skip to main content

Table 3 Percentage of patients in which the several adverse reproductive health outcomes were identified, at the last follow-up

From: Adverse reproductive health outcomes in a cohort of young women with breast cancer exposed to systemic treatments

Adverse outcome

Oligo/ amenorrhea

AMH < LoQ

AMH < expected for age

AFC < expected for age

FSH > 25 mIU/mL

No recovery of ovarian function

Premature Ovarian Insufficiency

 Percentage of patients presenting the outcome (total number of patients evaluated)

71% (35)

55% (38)

86% (35)

95% (21)

25% (36)

53% (19)

23% (22)

  1. AFC Antral Follicle Count, AMH Anti-Mullerian Hormone, FSH Follicle-Stimulating Hormone, LoQ Limit of Quantification